Financial Performance - Operating revenue for the first nine months of 2024 reached CNY 232,897,413.29, representing a year-on-year increase of 13.25% from CNY 205,648,012.74[5]. - Net profit attributable to shareholders for the first nine months of 2024 was CNY 46,772,231.88, a decrease of 3.01% compared to CNY 48,226,017.29 in the same period last year[5]. - The total comprehensive income for the first nine months of 2024 was CNY 46,415,101.87, down from CNY 48,144,569.47 in the same period last year, a decrease of about 3.0%[23]. - The total profit for the first nine months of 2024 was CNY 52,781,138.37, compared to CNY 54,497,696.05 in the same period last year, indicating a decrease of about 3.2%[23]. - The company's operating profit for the current period was CNY 52,772,952.58, a slight decrease from CNY 54,533,163.93 in the previous year, representing a decline of approximately 3.2%[23]. - The net profit for the first nine months of 2024 was CNY 46,809,901.87, slightly down from CNY 47,968,969.47 in the previous year, indicating a decrease of about 2.4%[23]. Cash Flow and Liquidity - The net cash flow from operating activities improved by 63.91%, amounting to CNY -11,278,326.54, compared to CNY -31,253,917.12 in the previous year[5]. - Operating cash inflow for the first nine months of 2024 was CNY 194,726,146.84, an increase of 7.8% compared to CNY 181,626,112.58 in the same period of 2023[26]. - Cash flow from operating activities for the parent company was CNY -40,179,506.44, worsening from CNY -27,011,490.15 year-over-year[29]. - The ending cash and cash equivalents balance for the first nine months of 2024 was CNY 73,205,288.29, compared to CNY 57,687,837.60 at the end of the same period in 2023[27]. - The company's cash and cash equivalents decreased to CNY 82,917,546.02 from CNY 116,059,679.78, representing a decline of approximately 28.6%[15]. - The parent company reported cash inflow from sales of CNY 193,893,267.75, up from CNY 177,814,213.72 in the previous year[28]. Assets and Liabilities - Total assets as of September 30, 2024, amounted to CNY 660,345,991.17, a decrease of 0.46% compared to CNY 663,385,343.21 at the end of 2023[5]. - The total liabilities decreased to CNY 102,928,116.82 from CNY 106,471,272.53, reflecting a reduction of approximately 3.5%[17]. - The company's equity attributable to shareholders increased slightly to CNY 556,121,793.10 from CNY 555,655,659.42, showing a marginal growth of about 0.08%[17]. - Accounts receivable increased significantly to CNY 331,064,243.54, up from CNY 267,267,274.11, indicating a growth of about 23.8%[15]. - The total non-current assets amounted to CNY 87,827,302.62, a slight increase from CNY 86,071,146.33, reflecting a growth of approximately 2.0%[16]. - Total liabilities decreased to ¥108,840,668.39 as of September 30, 2024, compared to ¥144,983,198.19 at the end of 2023, indicating a decline of approximately 25%[21]. Expenses and Costs - Total operating costs for the first nine months of 2024 were ¥175,613,586.14, up from ¥147,852,223.34 in 2023, indicating an increase of about 18.8%[22]. - Research and development expenses for the first nine months of 2024 amounted to ¥18,439,237.45, compared to ¥15,351,702.76 in 2023, reflecting a rise of approximately 20.3%[22]. - The company reported a significant increase in management expenses by 37.21%, totaling CNY 26,956,443.80, primarily due to stock incentive expenses[8]. - Research and development expenses increased to CNY 16,169,179.43 from CNY 13,421,547.23, marking a rise of approximately 20.6%[24]. Shareholder Information - The total number of ordinary shares at the end of the reporting period was 139,497,776, with 82.35% being unrestricted shares[10]. - Major shareholders include Jiang Xiaogang with 28.88% and Beijing Xinhua Jikang Investment Management Co., Ltd. with 5.77%[11]. - The company experienced a change in its shareholding structure, with a reduction of 62,926,879 restricted shares[10]. - The number of ordinary shareholders increased to 3,203 by the end of the reporting period[10]. - The company has implemented an employee stock option plan approved on September 15, 2023, to incentivize staff[13]. Strategic Initiatives - The company plans to expand its market presence and invest in new product development, although specific figures were not disclosed in the report[2]. - The company’s management indicated plans for market expansion and new product development in the upcoming quarters, aiming to enhance revenue streams and profitability[24]. - The company plans to continue investing in new product development and market expansion strategies to drive future growth[22]. Legal and Compliance - There were no significant legal disputes, external guarantees, or related party transactions reported during the period[12]. - The company disclosed a commitment related to its operations in announcement number 2024-045[12]. - The company's financial data adjustments were not applicable for this reporting period[9].

才华资本、青岛农商银行。（以上排名不分先后） （三）上市公司接待人员 证券代码：830879 证券简称：基康仪器 公告编号：2024-072 基康仪器股份有限公司 投资者关系活动记录表 | --- | --- | |------------------------------------------------------------------------|-------| | | | | 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 | | | 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 | | | 带法律责任。 | | 一、 投资者关系活动类别 □特定对象调研 □业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 √其他 (电话会议) 二、 投资者关系活动情况 （一）活动时间、地点 活动时间：2024 年 10 月 15 日 活动地点：公司通过进门财经网络交流平台以网络电话形式交流 （二）参与单位及人员 | --- | |------------------------------------------------------ ...

才华资本、青岛农商银行。（以上排名不分先后） （三）上市公司接待人员 证券代码：830879 证券简称：基康仪器 公告编号：2024-072 基康仪器股份有限公司 投资者关系活动记录表 | --- | --- | |------------------------------------------------------------------------|-------| | | | | 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 | | | 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 | | | 带法律责任。 | | 一、 投资者关系活动类别 □特定对象调研 □业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 √其他 (电话会议) 二、 投资者关系活动情况 （一）活动时间、地点 活动时间：2024 年 10 月 15 日 活动地点：公司通过进门财经网络交流平台以网络电话形式交流 （二）参与单位及人员 | --- | |------------------------------------------------------ ...

Investment Rating - The report assigns an "Accumulate" rating for the company, marking its first coverage [5][10]. Core Viewpoints - The company is a leading manufacturer in the field of safety monitoring, specializing in precision sensors and smart data acquisition devices. It has extensive project experience and is a primary supplier for major projects such as the South-to-North Water Diversion and the Three Gorges Dam. The company is expected to benefit from the peak investment cycle in water conservancy, hydropower, pumped storage, and nuclear power projects [3][7]. - The company has a solid order backlog, with operating cash flow remaining strong and consistent dividend payments, indicating both value and growth attributes [3][7]. Summary by Relevant Sections Company Overview - The company, founded in 1998, focuses on the research, production, and sales of smart monitoring terminals, including precision sensors and smart data acquisition devices. It operates a direct sales model targeting state-owned enterprises and research institutions in various sectors [16][17]. Market Position - The company holds a market share of 6% in the safety monitoring sector, positioning it as a leading player in the industry. The overall instrument and meter industry in China achieved a revenue of 10,112 billion yuan in 2023, with a CAGR of 8.7% from 2019 to 2023 [23][24]. Financial Performance - The company reported a revenue of 3.3 billion yuan in 2023, reflecting a 10% year-on-year growth, with a compound annual growth rate (CAGR) of 17.8% from 2019 to 2023. The net profit attributable to shareholders was 726.6 million yuan, up 20% year-on-year [17][21]. Growth Drivers - The water conservancy sector is experiencing a historical high in investment, driven by national policies and the issuance of 1 trillion yuan in government bonds. The energy sector, particularly pumped storage and nuclear power, is also seeing accelerated project approvals and construction [25][29]. - The company’s order backlog reached 360 million yuan at the beginning of 2024, primarily from pumped storage and water diversion projects [7][10]. Profitability and Valuation - The company is expected to achieve revenues of 361 million yuan, 438 million yuan, and 527 million yuan from 2024 to 2026, with a CAGR of 17.1%. The net profit attributable to shareholders is projected to be 78.24 million yuan, 94.95 million yuan, and 114.59 million yuan for the same period, with a CAGR of 16.4% [10][11].

证券简称：基康仪器 证券代码：830879 上海荣正企业咨询服务（集团）股份有限公司 关于 基康仪器股份有限公司 2023年股权激励计划 第一个行权期行权条件成就相关事项 之 独立财务顾问报告 1 | | | 一、释义 | 基康仪器、本公司、 公司、上市公司 | 指 | 基康仪器股份有限公司 | | --- | --- | --- | | 财务顾问、独立财务 | | | | 顾问 | 指 | 上海荣正企业咨询服务（集团）股份有限公司 | | 财务顾问报告、独立 | | 《上海荣正企业咨询服务（集团）股份有限公司关于基康仪器股 | | 财务顾问报告、本报 | 指 | 份有限公司2023年股权激励计划第一个行权期行权条件成就相关 | | 告 | | 事项之独立财务顾问报告》 | | 本激励计划、激励计 | | | | 划、本计划、2023年 | 指 | 《基康仪器股份有限公司2023年股权激励计划（草案）》 | | 激励计划 | | | | 股票期权 | 指 | 公司授予激励对象在未来一定期限内以预先确定的价格和条件购 | | | | 买本公司一定数量股票的权利 | | 激励对象 | | 按照本激励计划规定，获得 ...

证券代码：830879 证券简称：基康仪器 公告编号：2024-071 基康仪器股份有限公司 关于调整 2023 年股权激励计划股票期权行权价格的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 基康仪器股份有限公司（以下简称"公司"）于 2024 年 9 月 24 日召开第四 届董事会第十一次临时会议和第四届监事会第十一次临时会议，审议通过《关于 调整 2023 年股权激励计划股票期权行权价格的议案》。根据《上市公司股权激励 管理办法》（以下简称"《管理办法》"）、《北京证券交易所上市公司持续监管指引 第 3 号——股权激励和员工持股计划》（以下简称"《监管指引第 3 号》"）、《2023 年股权激励计划（草案）》（以下或简称"《激励计划》"、"2023 年股权激励计划"、 "本激励计划"）的相关规定及 2023 年第三次临时股东大会的授权，鉴于公司 2023 年度权益分派以及 2024 年半年度权益分派已实施完毕，公司拟对本激励计 划股票期权的行权价格进行调整，具体情况如下： 一、《激励计划》已 ...

GRANDWAY 北京国枫律师事务所 Grandway Law Offices 北京市东城区建国门内大街 26 号新闻大厦 7 层 邮编：100005 电话(Tel): 010—66090088/88004488 传真(Fax): 010—66090016 目 录 | 释 义 | | --- | | 一、本次调整行权价格及行权的批准与授权程序 | | 二、本次调整行权价格的具体情况… | | (一) 本次调整的依据 | | (二)本次调整的结果 … | | 三、本次行权条件的成就情况 | | 四、结论性意见 | 北京国枫律师事务所 关于基康仪器股份有限公司 2023 年股权激励计划 调整行权价格及第一个行权期行权条件成就的 法律意见书 国枫律证字[2023]AN150-3号 释 义 本法律意见书中,除非文义另有所指,下列词语或简称具有如下含义: | 基康仪器、公司 | 指 | 基康仪器股份有限公司 | | --- | --- | --- | | 本激励计划、股 | 指 | 基康仪器股份有限公司 2023 年股权激励计划 | | 权激励计划 | | | | 股票期权、期权 | 損 | 公司授予激励对象在未来一定 ...

1.2023 年 8 月 30 日，公司召开第四届董事会第五次临时会议，审议通过《关 于公司<2023 年股权激励计划（草案）>的议案》《关于公司<2023 年股权激励计 划授予的激励对象名单>的议案》《关于公司<2023 年股权激励计划实施考核管 理办法>的议案》以及《关于认定公司核心员工的议案》《关于提请股东大会授 权董事会办理 2023 年股权激励计划有关事项的议案》。公司独立董事对相关议 案发表了同意的独立意见。独立董事王英兰女土作为征集人就公司 2023 年第三 次临时股东大会审议的本次激励计划相关议案向公司全体股东征集投票权。 2.2023 年 8 月 30 日，公司召开第四届监事会第五次临时会议，审议通过《关 行权条件成就的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 基康仪器股份有限公司（以下简称"公司"）于 2024 年 9 月 24 日召开第四 届董事会第十一次临时会议和第四届监事会第十一次临时会议，审议通过《关于 公司 2023 年股权激励计划第一个行权期行权条件成就的议案 ...

基康仪器股份有限公司 第四届董事会第十一次临时会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 证券代码：830879 证券简称：基康仪器 公告编号：2024-067 （一）会议召开情况 1.会议召开时间：2024 年 9 月 24 日 2.会议召开地点：公司会议室 3.会议召开方式：现场及通讯方式 4.发出董事会会议通知的时间和方式：2024 年 9 月 18 日以邮件方式发出 5.会议主持人：董事长袁双红先生 6.会议列席人员：监事、高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法律、 法规、部门规章、规范性文件和《公司章程》的有关规定。 （二）会议出席情况 会议应出席董事 9 人，出席董事 9 人。 董事沈省三先生、赵初林先生因外出以通讯方式出席。 等相关规定，公司《2023 年股权激励计划（草案）》第一个行权期的行权条件 已经成就，符合行权条件的激励对象共计 44 名，可行权的股票期权数量为 ...

证券代码：830879 证券简称：基康仪器 公告编号：2024-068 基康仪器股份有限公司 第四届监事会第十一次临时会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 5.会议主持人：邹勇军先生 6.召开情况合法、合规、合章程性说明： 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法律、 法规、部门规章、规范性文件和《公司章程》的有关规定。 （二）会议出席情况 会议应出席监事 3 人，出席监事 3 人。 二、议案审议情况 （一）审议通过《关于公司 2023 年股权激励计划第一个行权期行权条件成就的 议案》 1.议案内容： 根据《上市公司股权激励管理办法》、公司《2023 年股权激励计划（草案）》 等相关规定，公司《2023 年股权激励计划（草案）》第一个行权期的行权条件 已经成就，符合行权条件的激励对象共计 44 名，可行权的股票期权数量为 1.会议召开时间：2024 年 9 月 24 日 2.会议召开地点：公司会议室 3.会议召开方 ...